Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Papini

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
British Journal of Haematology|February 3, 2012
Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemiaAlessandro Gozzetti, Pellegrino Musto, Marzia Defina, et al.
Leukemia Research|June 18, 2014
Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemiaAlessandro Gozzetti, Veronica Candi, Alberto Fabbri, et al.
Clinical and Experimental Medicine|March 7, 2026
Real‑life diagnostic and therapeutic approach to CLL/SLL in tuscany: the 2025 consensusMaria D'Amato, Chiara Maria Rapolla, Edoardo Benedetti, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
British Journal of Haematology|February 3, 2012
Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemiaAlessandro Gozzetti, Pellegrino Musto, Marzia Defina, et al.
Leukemia Research|June 18, 2014
Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemiaAlessandro Gozzetti, Veronica Candi, Alberto Fabbri, et al.
Clinical and Experimental Medicine|March 7, 2026
Real‑life diagnostic and therapeutic approach to CLL/SLL in tuscany: the 2025 consensusMaria D'Amato, Chiara Maria Rapolla, Edoardo Benedetti, et al.
Pageof 2